Chicago, Illinois, United States In 1950 was created Muscular Dystrophy Association, which is appeared as Corporate Investor. The leading representative office of defined Corporate Investor is situated in the Chicago. The venture was found in North America in United States.
The top activity for fund was in 2019. The fund is constantly included in less than 2 investment rounds annually. The common things for fund are deals in the range of 100 thousands - 1 million dollars.
The typical case for the fund is to invest in rounds with 1 participant. Despite the Muscular Dystrophy Association, startups are often financed by UCB Ventures, Temasek Holdings, Lightstone Ventures.
We can highlight the next thriving fund investment areas, such as Biotechnology. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline Locana Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund.
Related Funds
| Fund Name | Location |
| Continental Bank | - |
| Cope Ventures | - |
| Daiwa Energy Infrastructure | - |
| Forticom | Latvia, Riga, Vidzeme |
| Gund Investment, LLC | New Jersey, Princeton, United States |
| Hamashin Lease | Hamamatsu, Japan, Shizuoka Prefecture |
| ISF, Inc. | Florida, Jacksonville, United States |
| Kyber Capital | - |
| Miyako Capital | Japan, Kyoto, Kyoto Prefecture |
| ModiQuest B.V. | - |
| Pilot Grove | - |
| RapidTainment | Cham, Switzerland, Zug |
| SAS | Cary, North Carolina, United States |
| Securian Financial Group | Minnesota, Saint Paul, United States |
| The Net Group | - |
| Transamerica | Cedar Rapids, Iowa, United States |
| Updata Partners | District of Columbia, United States, Washington |
| Xuanshi Tiancheng | - |
| Zhongtianlida Feng Tou | Beijing, Beijing, China |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Myosana Therapeutics | $5M | 07 Dec 2022 | Seattle, Washington, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Myosana Therapeutics | $5M | 07 Dec 2022 | Seattle, Washington, United States |
